Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


17.12.2018

1 Am J Obstet Gynecol
1 Anal Chim Acta
2 Arch Gynecol Obstet
1 Biosci Trends
2 BMC Cancer
1 BMJ Case Rep
1 Br J Radiol
1 Cancer
1 Cancer Biomark
1 Cancer Cell Int
1 Cancer Control
1 Cancer Epidemiol
2 Cancer Manag Res
1 Cancer Treat Res
1 Clin Radiol
1 Clinics (Sao Paulo)
1 Colloids Surf B Biointerfaces
1 Dermatol Online J
1 Dis Markers
1 Eur J Nucl Med Mol Imaging
2 Eur J Obstet Gynecol Reprod Biol
1 Eur Rev Med Pharmacol Sci
1 Exp Ther Med
1 Fam Pract
2 Front Immunol
1 Front Microbiol
1 Int J Cancer
1 Int J Equity Health
1 IUBMB Life
1 J Clin Med
1 J Glob Health Rep
1 J Hematol Oncol
4 J Low Genit Tract Dis
2 J Obstet Gynaecol Can
1 Jpn J Clin Oncol
1 Klin Onkol
1 Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
2 Magy Onkol
1 Medicine (Baltimore)
1 Mikrobiyol Bul
2 Mol Med Rep
1 Nanomedicine (Lond)
1 Nanotechnology
1 Nat Commun
1 Nutr Hosp
1 Onco Targets Ther
1 Oncol Lett
14 Rep Pract Oncol Radiother
1 Reprod Health
1 Saudi Med J
1 Soc Sci Med
1 Virusdisease
1 Wideochir Inne Tech Maloinwazyjne
1 Yonsei Med J
1 Zhonghua Nan Ke Xue
1 Zhonghua Yu Fang Yi Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Obstet Gynecol

  1. BRUSSELAERS N, Shrestha S, Van De Wijgert J, Verstraelen H, et al
    Vaginal dysbiosis, and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis.
    Am J Obstet Gynecol. 2018 Dec 11. pii: S0002-9378(18)32221.
    PubMed     Text format     Abstract available


    Anal Chim Acta

  2. FENG Y, Guo Y, Li Y, Tao J, et al
    Lectin-mediated in situ rolling circle amplification on exosomes for probing cancer-related glycan pattern.
    Anal Chim Acta. 2018;1039:108-115.
    PubMed     Text format     Abstract available


    Arch Gynecol Obstet

  3. SEEBACHER V, Sturdza A, Bergmeister B, Polterauer S, et al
    Factors associated with post-relapse survival in patients with recurrent cervical cancer: the value of the inflammation-based Glasgow Prognostic Score.
    Arch Gynecol Obstet. 2018 Dec 10. pii: 10.1007/s00404-018-4993.
    PubMed     Text format     Abstract available

  4. VITALE SG, Capriglione S, Zito G, Lopez S, et al
    Management of endometrial, ovarian and cervical cancer in the elderly: current approach to a challenging condition.
    Arch Gynecol Obstet. 2018 Dec 12. pii: 10.1007/s00404-018-5006.
    PubMed     Text format     Abstract available


    Biosci Trends

  5. LIN X, Qiu J, Hua K
    Long non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in gynecologic cancers.
    Biosci Trends. 2018;12:342-353.
    PubMed     Text format     Abstract available


    BMC Cancer

  6. NYAMBE A, Kampen JK, Baboo SK, Van Hal G, et al
    The impact of the social environment on Zambian cervical cancer prevention practices.
    BMC Cancer. 2018;18:1242.
    PubMed     Text format     Abstract available

  7. ABULIZI G, Zhang YY, Mijiti P, Li H, et al
    Serum Se, Ni, and As are associated with HPV infection and CIN2+ among Uyghur women in rural China.
    BMC Cancer. 2018;18:925.
    PubMed     Text format     Abstract available


    BMJ Case Rep

  8. SRIVASTAVA P, Rath S, Hadi R, Husain N, et al
    Primary amelanotic malignant melanoma of cervix masquerading as squamous cell carcinoma presenting with extensive metastases.
    BMJ Case Rep. 2018;2018.
    PubMed     Text format     Abstract available


    Br J Radiol

  9. LEWIS S, Chopra S, Naga P, Pant S, et al
    Acute hematological toxicity during post-operative bowel sparing image-guided intensity modulated radiation with concurrent cisplatin.
    Br J Radiol. 2018;91:20180005.
    PubMed     Text format     Abstract available


    Cancer

  10. PRINTZ C
    High-risk human papillomavirus test a good option for cervical cancer screening.
    Cancer. 2018;124:4591.
    PubMed     Text format    


    Cancer Biomark

  11. SUROV A, Meyer HJ, Hohn AK, Schob S, et al
    Metabolo-volumetric parameters of 18F-FDG-PET can predict expression of EGFR and HIF 1alpha in uterine cervical cancer.
    Cancer Biomark. 2018 Nov 26. pii: CBM182019. doi: 10.3233/CBM-182019.
    PubMed     Text format     Abstract available


    Cancer Cell Int

  12. XU Y, He Q, Lu Y, Tao F, et al
    MicroRNA-218-5p inhibits cell growth and metastasis in cervical cancer via LYN/NF-kappaB signaling pathway.
    Cancer Cell Int. 2018;18:198.
    PubMed     Text format     Abstract available


    Cancer Control

  13. SAHIN E, Madendag Y, Sahin ME, Madendag IC, et al
    Cervical Local Immune Response for High-Risk Human Papillomavirus Infection: Involvement With Cervical Mucus SLPI Proteins.
    Cancer Control. 2018;25:1073274818798598.
    PubMed     Text format     Abstract available


    Cancer Epidemiol

  14. CRAMPE-CASNABET C, Franck JE, Ringa V, Coeuret-Pellicer M, et al
    Role of obesity in differences in cervical cancer screening rates by migration history. The CONSTANCES survey.
    Cancer Epidemiol. 2018;58:98-103.
    PubMed     Text format     Abstract available


    Cancer Manag Res

  15. ZHOU L, Kong Q, Zhang Y, Yang W, et al
    Glucose deprivation promotes apoptotic response to S1 by enhancing autophagy in human cervical cancer cells.
    Cancer Manag Res. 2018;10:6195-6204.
    PubMed     Text format     Abstract available

  16. OBASI TC, Braicu C, Iacob BC, Bodoki E, et al
    Securidaca-saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells.
    Cancer Manag Res. 2018;10:5709-5724.
    PubMed     Text format     Abstract available


    Cancer Treat Res

  17. DU P
    Human Papillomavirus Infection and Cervical Cancer in HIV+ Women.
    Cancer Treat Res. 2019;177:105-129.
    PubMed     Text format     Abstract available


    Clin Radiol

  18. DU S, Sun H, Gao S, Xin J, et al
    Relationship between (18)F-FDG PET metabolic parameters and MRI intravoxel incoherent motion (IVIM) histogram parameters and their correlations with clinicopathological features of cervical cancer: evidence from integrated PET/MRI.
    Clin Radiol. 2018 Dec 10. pii: S0009-9260(18)30586.
    PubMed     Text format     Abstract available


    Clinics (Sao Paulo)

  19. SILVA GAF, Nunes RAL, Morale MG, Boccardo E, et al
    Oxidative stress: therapeutic approaches for cervical cancer treatment.
    Clinics (Sao Paulo). 2018;73.
    PubMed     Text format     Abstract available


    Colloids Surf B Biointerfaces

  20. LI C, Huang H, Cui R, Li J, et al
    Fluorescent activatable gadofullerene nanoprobes as NIR-MR dual-modal in vivo imaging contrast agent.
    Colloids Surf B Biointerfaces. 2018;171:159-166.
    PubMed     Text format     Abstract available


    Dermatol Online J

  21. BESSALELI E, Scheinfeld N, Kroumpouzos- G
    Squamous cell carcinoma of the cervix arising in a patient on adalimumab a need for cervical screenings in patients on tumor necrosis factor inhibitors.
    Dermatol Online J. 2018;24.
    PubMed     Text format     Abstract available


    Dis Markers

  22. FAN Y, Meng Y, Yang S, Wang L, et al
    Screening of Cervical Cancer with Self-Collected Cervical Samples and Next-Generation Sequencing.
    Dis Markers. 2018;2018:4826547.
    PubMed     Text format     Abstract available


    Eur J Nucl Med Mol Imaging

  23. LUCIA F, Visvikis D, Vallieres M, Desseroit MC, et al
    External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy.
    Eur J Nucl Med Mol Imaging. 2018 Dec 7. pii: 10.1007/s00259-018-4231.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  24. GODFREY MAL, Nikolopoulos M, Garner JE, Adib TR, et al
    Conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women under 30 years of age: A cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2018;228:267-273.
    PubMed     Text format     Abstract available

  25. PACKET B, Poppe W, Weynand B, Vanherck M, et al
    The use of p16/Ki-67 dual staining technology on cervical cytology of patients undergoing a LLETZ procedure.
    Eur J Obstet Gynecol Reprod Biol. 2018;228:191-196.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  26. WANG N, Hou MS, Zhan Y, Shen XB, et al
    MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway.
    Eur Rev Med Pharmacol Sci. 2018;22:7653-7659.
    PubMed     Text format     Abstract available


    Exp Ther Med

  27. WANG W, Yao S, Jiang H, Dong J, et al
    Upstream transcription factor 1 prompts malignancies of cervical cancer primarily by transcriptionally activating p65 expression.
    Exp Ther Med. 2018;16:4415-4422.
    PubMed     Text format     Abstract available


    Fam Pract

  28. IFEDIORA CO, Azuike EC
    Targeting cervical cancer campaigns on teenage high schoolers in resource-limited economies: lessons from an intervention study of Nigerian senior secondary school girls.
    Fam Pract. 2018 Dec 12. pii: 5239763. doi: 10.1093.
    PubMed     Text format     Abstract available


    Front Immunol

  29. MAESTRI CA, Nisihara R, Mendes HW, Jensenius J, et al
    MASP-1 and MASP-2 Serum Levels Are Associated With Worse Prognostic in Cervical Cancer Progression.
    Front Immunol. 2018;9:2742.
    PubMed     Text format     Abstract available

  30. CUI JH, Lin KR, Yuan SH, Jin YB, et al
    TCR Repertoire as a Novel Indicator for Immune Monitoring and Prognosis Assessment of Patients With Cervical Cancer.
    Front Immunol. 2018;9:2729.
    PubMed     Text format     Abstract available


    Front Microbiol

  31. WANG X, Huang X, Zhang Y
    Involvement of Human Papillomaviruses in Cervical Cancer.
    Front Microbiol. 2018;9:2896.
    PubMed     Text format     Abstract available


    Int J Cancer

  32. ANDREASSEN T, Hansen BT, Engesaeter B, Hashim D, et al
    Psychological Effect of Cervical Cancer Screening When Changing Primary Screening Method From Cytology to hrHPV testing.
    Int J Cancer. 2018 Dec 14. doi: 10.1002/ijc.32067.
    PubMed     Text format     Abstract available


    Int J Equity Health

  33. MERINO-VENTOSA M, Urbanos-Garrido RM
    Changes in income-related inequalities in cervical cancer screening during the Spanish economic crisis: a decomposition analysis.
    Int J Equity Health. 2018;17:184.
    PubMed     Text format     Abstract available


    IUBMB Life

  34. XU J, Xu S, Fang Y, Chen T, et al
    Cyclin-dependent kinase 9 promotes cervical cancer development via AKT2/p53 pathway.
    IUBMB Life. 2018 Dec 11. doi: 10.1002/iub.1983.
    PubMed     Text format     Abstract available


    J Clin Med

  35. CAMUS C, Vitale S, Loubatier C, Penaranda G, et al
    Quantification of HPV16 E6/E7 mRNA Spliced Isoforms Viral Load as a Novel Diagnostic Tool for Improving Cervical Cancer Screening.
    J Clin Med. 2018;7.
    PubMed     Text format     Abstract available


    J Glob Health Rep

  36. HERNANDEZ BY, Tareg AC, Reichhardt M, Agapito A, et al
    Randomized controlled trial evaluating the utility of urine HPV DNA for cervical cancer screening in a Pacific Island population.
    J Glob Health Rep. 2018;2.
    PubMed     Text format     Abstract available


    J Hematol Oncol

  37. JIANG W, He T, Liu S, Zheng Y, et al
    The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the beta-catenin/SIRT3 signaling pathway in cervical cancer.
    J Hematol Oncol. 2018;11:139.
    PubMed     Text format     Abstract available


    J Low Genit Tract Dis

  38. KILFOYLE KA, Des Marais AC, Ngo MA, Romocki L, et al
    Preference for Human Papillomavirus Self-Collection and Papanicolaou: Survey of Underscreened Women in North Carolina.
    J Low Genit Tract Dis. 2018;22:302-310.
    PubMed     Text format     Abstract available

  39. MOLOKWU JC, Penaranda E, Dwivedi A, Mallawaarachchi I, et al
    Effect of Educational Intervention on Self-Sampling Acceptability and Follow-Up Paps in Border Dwelling Hispanic Females.
    J Low Genit Tract Dis. 2018;22:295-301.
    PubMed     Text format     Abstract available

  40. CHEN W, Sun H, Molijn A, Zeng L, et al
    The Variable Characteristics of Human Papillomavirus in Squamous Cell Carcinoma and Adenocarcinoma of Cervix in China.
    J Low Genit Tract Dis. 2018;22:355-361.
    PubMed     Text format     Abstract available

  41. MUNMANY M, Torne A, Nonell R, Barnadas E, et al
    Colposcopy Evaluation at the Time of Loop Electrosurgical Excision Procedure May Avoid Unnecessary Treatment.
    J Low Genit Tract Dis. 2018;22:367-374.
    PubMed     Text format     Abstract available


    J Obstet Gynaecol Can

  42. MATANES E, Abitbol J, Kessous R, Kogan L, et al
    Oncologic and Surgical Outcomes of Robotic Versus Open Radical Hysterectomy for Cervical Cancer.
    J Obstet Gynaecol Can. 2018 Dec 7. pii: S1701-2163(18)30755.
    PubMed     Text format     Abstract available

  43. BLAKE J
    The Elimination of Cervical Cancer in Our Lifetime.
    J Obstet Gynaecol Can. 2018;40:1555-1557.
    PubMed     Text format    


    Jpn J Clin Oncol

  44. MORISADA T, Saika K, Saito E, Kono K, et al
    Population-based cohort study assessing the efficacy of cervical cytology (Pap smear) and human papillomavirus (HPV) testing as modalities for cervical cancer screening.
    Jpn J Clin Oncol. 2018;48:495-498.
    PubMed     Text format     Abstract available


    Klin Onkol

  45. TAHERI M, Ghafouri-Fard S
    Long Non-Cod-ing RNA Signature in Cervical Cancer.
    Klin Onkol. 2018;31:403-408.
    PubMed     Text format     Abstract available


    Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi

  46. HU ZZ, Li DM, Wang Y, Wang J, et al
    [Metastases of cervical cancer to the nasal cavity and paranasal sinus with maxillofacial symptoms: a case report].
    Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018;32:1832-1833.
    PubMed     Text format     Abstract available


    Magy Onkol

  47. VIZKELETI J, Frohlich G, Nhung NA, Horvath K, et al
    [Clinical results of combined intracavitary-interstitial image-guided adaptive brachytherapy in locally advanced cervical cancer].
    Magy Onkol. 2018;62:249-257.
    PubMed     Text format     Abstract available

  48. FROHLICH G, Vizkeleti J, Nhung NA, Horvath K, et al
    [Dosimetric evaluation of intracavitary-interstitial image-guided adaptive brachytherapy of cervical cancer and comparison with conventional treatment techniques].
    Magy Onkol. 2018;62:242-248.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  49. LEE B, Kim K, Park Y, Lim MC, et al
    Impact of hospital care volume on clinical outcomes of laparoscopic radical hysterectomy for cervical cancer: A systematic review and meta-analysis.
    Medicine (Baltimore). 2018;97:e13445.
    PubMed     Text format     Abstract available


    Mikrobiyol Bul

  50. GOKTUG KADIOGLU B, Cinar Tanriverdi E, Alay H, Ucar M, et al
    [Relation of cervical cancer with the results of human papillomavirus (HPV) screening carried out via hybrid capture 2 method on 52.000 women in Erzurum].
    Mikrobiyol Bul. 2018;52:367-375.
    PubMed     Text format     Abstract available


    Mol Med Rep

  51. SHI L, Han F, Shi C, Huang Y, et al
    Immunohistochemical detection of E7 human papillomavirus protein in premalignant and malignant lesions of the uterine cervix.
    Mol Med Rep. 2018;18:3949-3956.
    PubMed     Text format     Abstract available

  52. WANG X, Lin Y, Liu J
    Long noncoding RNA DLX6AS1 promotes proliferation by acting as a ceRNA targeting miR199a in cervical cancer.
    Mol Med Rep. 2018 Dec 7. doi: 10.3892/mmr.2018.9729.
    PubMed     Text format     Abstract available


    Nanomedicine (Lond)

  53. FU J, Qiu L
    Photo-crosslinked and esterase-sensitive polymersome for improved antitumor effect of water-soluble chemotherapeutics.
    Nanomedicine (Lond). 2018;13:2051-2066.
    PubMed     Text format     Abstract available


    Nanotechnology

  54. XIAO L, Ma N, He H, Li J, et al
    Development of a novel drug targeting delivery system for cervical cancer therapy.
    Nanotechnology. 2018 Nov 26. doi: 10.1088/1361-6528.
    PubMed     Text format     Abstract available


    Nat Commun

  55. ZHANG G, Li X, Liao Q, Liu Y, et al
    Water-dispersible PEG-curcumin/amine-functionalized covalent organic framework nanocomposites as smart carriers for in vivo drug delivery.
    Nat Commun. 2018;9:2785.
    PubMed     Text format     Abstract available


    Nutr Hosp

  56. DE LOERA RODRIGUEZ LH, Ortiz GG, Rivero Moragrega P, Velazquez Brizuela IE, et al
    Effect of symbiotic supplementation on fecal calprotectin levels and lactic acid bacteria, Bifidobacteria, Escherichia coli and Salmonella DNA in patients with cervical cancer.
    Nutr Hosp. 2018;35:1394-1400.
    PubMed     Text format     Abstract available


    Onco Targets Ther

  57. SHI X, Qiu S, Zhuang W, Wang C, et al
    Follicle-stimulating hormone inhibits cervical cancer via NF-kappaB pathway.
    Onco Targets Ther. 2018;11:8107-8115.
    PubMed     Text format     Abstract available


    Oncol Lett

  58. MIN Z, Pu X, Gu Z
    Correlative analysis of the expression of IL-10 and Ki-67 in human cervical cancer and cervical intraepithelial neoplasias and human papillomavirus infection.
    Oncol Lett. 2018;16:7189-7194.
    PubMed     Text format     Abstract available


    Rep Pract Oncol Radiother

  59. NOVIKOV SN, Krzhivitskii PI, Kanaev SV, Berlev IV, et al
    Lymph flow guided irradiation of regional lymph nodes in patients with cervical cancer: Preliminary analysis of scintigraphic data.
    Rep Pract Oncol Radiother. 2018;23:503-509.
    PubMed     Text format     Abstract available

  60. DE LA TORRE M
    Neoadjuvant chemotherapy in woman with early or locally advanced cervical cancer.
    Rep Pract Oncol Radiother. 2018;23:528-532.
    PubMed     Text format     Abstract available

  61. BURCHARDT E, Roszak A
    Hyperthermia in cervical cancer - current status.
    Rep Pract Oncol Radiother. 2018;23:595-603.
    PubMed     Text format     Abstract available

  62. RIOS I, Vasquez I, Cuervo E, Garzon O, et al
    Problems and solutions in IGRT for cervical cancer.
    Rep Pract Oncol Radiother. 2018;23:517-527.
    PubMed     Text format     Abstract available

  63. VILLAFRANCA E, Navarrete P, Sola A, Muruzabal JC, et al
    Image-guided brachytherapy in cervical cancer: Experience in the Complejo Hospitalario de Navarra.
    Rep Pract Oncol Radiother. 2018;23:510-516.
    PubMed     Text format     Abstract available

  64. POITEVIN CHACON A, Chavez-Nogueda J, Ramos-Prudencio R, Villavicencio-Queijeiro MA, et al
    The role of para-aortic nodal irradiation in cervical cancer.
    Rep Pract Oncol Radiother. 2018;23:540-546.
    PubMed     Text format     Abstract available

  65. GLICKMAN AG, Valdes S, Gil-Ibanez B, Paredes P, et al
    Present status of sentinel lymph node biopsy in cervical cancer.
    Rep Pract Oncol Radiother. 2018;23:495-502.
    PubMed     Text format     Abstract available

  66. DIAZ M, de Sanjose S, Bosch FX, Bruni L, et al
    Present challenges in cervical cancer prevention: Answers from cost-effectiveness analyses.
    Rep Pract Oncol Radiother. 2018;23:484-494.
    PubMed     Text format     Abstract available

  67. ROVIROSA A, de la Torre M, Arenas M, Malicki J, et al
    New developments and controversies in cervical cancer.
    Rep Pract Oncol Radiother. 2018;23:481-483.
    PubMed     Text format    

  68. RICHART J, Carmona-Meseguer V, Garcia-Martinez T, Herreros A, et al
    Review of strategies for MRI based reconstruction of endocavitary and interstitial applicators in brachytherapy of cervical cancer.
    Rep Pract Oncol Radiother. 2018;23:547-561.
    PubMed     Text format     Abstract available

  69. TORNERO-LOPEZ AM, Guirado D
    Radiobiological considerations in combining doses from external beam radiotherapy and brachytherapy for cervical cancer.
    Rep Pract Oncol Radiother. 2018;23:562-573.
    PubMed     Text format     Abstract available

  70. REGALADO PORRAS GO, Chavez Nogueda J, Poitevin Chacon A
    Chemotherapy and molecular therapy in cervical cancer.
    Rep Pract Oncol Radiother. 2018;23:533-539.
    PubMed     Text format     Abstract available

  71. ORBEGOSO C, Murali K, Banerjee S
    The current status of immunotherapy for cervical cancer.
    Rep Pract Oncol Radiother. 2018;23:580-588.
    PubMed     Text format     Abstract available

  72. BIETE A, Oses G
    Intraoperative radiation therapy in uterine cervical cancer: A review.
    Rep Pract Oncol Radiother. 2018;23:589-594.
    PubMed     Text format     Abstract available


    Reprod Health

  73. MANGURO GO, Masese LN, Mandaliya K, Graham SM, et al
    Preference of specimen collection methods for human papillomavirus detection for cervical cancer screening: a cross-sectional study of high-risk women in Mombasa, Kenya.
    Reprod Health. 2018;15:206.
    PubMed     Text format     Abstract available


    Saudi Med J

  74. BOZDAG Z, Taslar AM, Tepe NB, Dizibuyuk OF, et al
    The re-awakening of hCG expression. Its role in the diagnosis of cervical squamous cell carcinoma.
    Saudi Med J. 2018;39:873-877.
    PubMed     Text format     Abstract available


    Soc Sci Med

  75. BROWN RF, Muller TR, Olsen A
    Australian women's cervical cancer screening attendance as a function of screening barriers and facilitators.
    Soc Sci Med. 2018;220:396-402.
    PubMed     Text format     Abstract available


    Virusdisease

  76. JAIN G, Sabeena S, Vasudeva A, Mundkur A, et al
    A report of human papilloma virus-16 associated vaginal carcinoma after thirty-two years of successful radiation therapy for cervical cancer.
    Virusdisease. 2018;29:537-539.
    PubMed     Text format     Abstract available


    Wideochir Inne Tech Maloinwazyjne

  77. CHEN L, Zhang WN, Zhang SM, Gao Y, et al
    Class I hysterectomy in stage Ia2-Ib1 cervical cancer.
    Wideochir Inne Tech Maloinwazyjne. 2018;13:494-500.
    PubMed     Text format     Abstract available


    Yonsei Med J

  78. CHOI E, Lee YY, Suh M, Lee EY, et al
    Socioeconomic Inequalities in Cervical and Breast Cancer Screening among Women in Korea, 2005-2015.
    Yonsei Med J. 2018;59:1026-1033.
    PubMed     Text format     Abstract available


    Zhonghua Nan Ke Xue

  79. PAN LJ, Ma JH, Zhang FL, Pan F, et al
    [HPV infection of the external genitalia in men whose female partners have cervical HPV infection].
    Zhonghua Nan Ke Xue. 2018;24:516-519.
    PubMed     Text format     Abstract available


    Zhonghua Yu Fang Yi Xue Za Zhi

  80. TAO SY, Peng JR, Wang Y, Zhang GT, et al
    [Study on direct economic burden and influencing factors in patients with cervical cancer and precancerous lesions].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52:1281-1286.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: